Biotech Values

[DewDiligence]

ABT’s Humira is the largest-selling drug in the world because the list of indications keeps growing and growing. ABT is now running phase-3 trials in yet another indication, hidradenitis suppurativa:

http://finance.yahoo.com/news/abbott-announces-patient-enrollment-two-100000194.html

Abbott today announced the initiation of two Phase 3 clinical trials designed to evaluate the safety and efficacy of an investigational use of HUMIRA® (adalimumab) in adult patients with moderate to severe hidradenitis suppurativa (HS). Hidradenitis suppurativa is a difficult-to-treat, chronic, inflammatory skin disease characterized by painful, recurrent abscesses, and nodules that primarily appear in the groin or under the armpits or breasts and start out as tender, swollen bumps. Over time, these lesions can fill with fluid, burst, and result in scars.